BIDMC Harvard Medical School Broad Institute

Since coming to the Gerszten lab in 2012 John has been involved in a number of projects, including studying GWAS-metabolite associations in cardiovascular disease, metabolic phenotyping of murine models of obesity and insulin resistance, and the metabolic perturbations caused by exercise and cardiac pacing. John is currently using non-targeted metabolomic profiling approaches for the discovery of novel markers of cardiometabolic disease, and investigating the metabolic consequences of genetic modification in cellular models of human disease.

Date posted: June 18, 2015 | Author: | Comments Off on John O’Sullivan


Comments are closed.